The International Prize for Scientific Research Arrigo Recordati has announced a Call for Nominations for 2019. The 2019 Award will be dedicated to the promotion and recognition of excellence in orphan disease treatment research.
The Prize was established in 2000 in memory of the Italian pharmaceutical entrepreneur Arrigo Recordati to carry on his legacy and to inspire scientists and researchers to make important discoveries benefiting people worldwide in the field of cardiovascular disease. However, in the last ten years, Recordati (the pharmaceutical company founded by Arrigo Recordati) has made the Rare Diseases field a health priority and increased its commitment worldwide through its dedicated subsidiaries Orphan Europe and Recordati Rare Diseases to research, develop and market a number of treatments for orphan diseases.
To reflect this commitment, the company has decided that the 2019 Edition of the International Prize for Scientific Research Arrigo Recordati will be dedicated to the promotion and recognition of excellence in orphan disease treatment research.
The Award is open to researchers of all nationalities who are not in any way directly affiliated with pharmaceutical or medical device companies.
International projects within the area of rare/orphan disease treatment in all therapeutic areas (except for oncology, hematology and immunology) are eligible to apply as long the disease concerned has a prevalence of not more than 1 in 2000.
The winning project will receive a research grant of €100,000.
Nominations follow a two-step procedure. Initial proposals consisting of a Summary Page and a Letter of Intent should be submitted by the deadline of 15 December 2018.
Selected applicants will be invited to submit Full Applications by 30 April 2019. The winning project will be announced during an Award Ceremony at the Society for the Study of Inborn Errors of Metabolism Congress (2019 SSIEM, Rotterdam) 2-6 September 2019.